We're pleased to announce a strategic partnership with Ivy Tree Advisors, the Boston-based management and strategy consultancy for biopharma and health tech. Led by Managing Partner Jonathan Olsen, Ivy Tree works alongside senior pharma leaders at top pharma companies on innovation, market entry, commercialization, and product launch, and helps organizations put digital, data, and AI strategy into practice.

Synthio Labs is building the AI-native engagement platform for life sciences, helping pharma, commercial and medical teams deploy clinical-grade voice AI systems at scale. Our platform spans AI agents for HCP and patient engagement, field companions, HCP intelligence, and AI-simulated market research. We are working with leading global pharma companies across production deployments in commercial, medical, and patient support use cases. Our platform is enterprise-ready, and integrates with existing CRM and data ecosystems.
‍

‍

The two firms will work in tandem to help pharma organizations move from AI ambition to measurable impact, pairing Ivy Tree's strategic counsel and industry relationships with Synthio Labs' solutions. Ivy Tree will also partner selectively with Synthio Labs to provide pharma companies an added layer of support on governance, organizational redesign, change management, transformation, and strategy as agentic workflows are applied across products, franchises, and departments. The partnership will focus on the moments where AI matters most: preparing for a launch, modernizing medical affairs, and deepening engagement with HCPs and patients.
‍

‍

To explore how Synthio Labs and Ivy Tree Advisors can support your organization, contact us today.